Progression of Atherosclerosis as Assessed by Carotid Intima-Media Thickness in Patients With HIV Infection
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background— HIV-infected patients may be at increased risk for coronary events. The purpose of this study was to identify predictors of carotid intima-media thickness (IMT) in HIV patients at baseline and to measure IMT progression over 1 year. Methods and Results— We measured blood lipids, inflammatory markers, and IMT in 148 HIV-infected adults (mean age, 45±8 years) and in 63 age- and sex-matched HIV-uninfected control subjects. The mean duration of HIV infection was 11 years, and the median duration of protease inhibitor treatment was 3.3 years. Mean baseline IMT was 0.91±0.33 mm in HIV patients and 0.74±0.17 mm in control subjects ( P =0.0001). Multivariable predictors of baseline IMT in HIV patients were age ( P <0.001), LDL cholesterol ( P <0.001), cigarette pack-years ( P =0.005), Latino race ( P =0.062), and hypertension ( P =0.074). When the control group was added to the analysis, HIV infection was an independent predictor of IMT ( P =0.001). The rate of progression among the 121 HIV patients with a repeated IMT measurement at 1 year was 0.074±0.13 mm, compared with −0.006±0.05 mm in 27 control subjects ( P =0.002). Age ( P <0.001), Latino race ( P =0.02), and nadir CD4 count ≤200 ( P =0.082) were multivariable predictors of IMT progression. Conclusions— Carotid IMT is higher in HIV patients than in age-matched control subjects and progresses much more rapidly than previously reported rates in non-HIV cohorts. In HIV patients, carotid IMT is associated with classic coronary risk factors and with nadir CD4 count ≤200, suggesting that immunodeficiency and traditional coronary risk factors may contribute to atherosclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1399 · Cited by 2,404
Bots, M. L., Hoes, A. W., Koudstaal, P. J., Hofman, A., & Grobbee, D. E. (1997) · Circulation · doi:10.1161/01.cir.96.5.1432 · Cited by 2,345
Chambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
Frostegård, J., Ulfgren, A.-K., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Furberg, C. D., Adams, H. P., Applegate, W. B., Byington, R. P., Espeland, M. A., Hartwell, T., Hunninghake, D. B., Lefkowitz, D. S., Probstfield, J., & Riley, W. A. (1994) · Circulation · doi:10.1161/01.cir.90.4.1679 · Cited by 867
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B., Hagos, E., Lampiris, H., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Self-citationGrunfeld, C. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.5.1045 · Cited by 848
Heiss, G., Sharrett, A. R., Barnes, R., Chambless, L. E., Szklo, M., & Alzola, C. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116078 · Cited by 839
Howard, G., Sharrett, A. R., Heiss, G., Evans, G. W., Chambless, L. E., Riley, W. A., & Burke, G. L. (1993) · Stroke · doi:10.1161/01.str.24.9.1297 · Cited by 724
Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022048 · Cited by 625
Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors
Périard, D., Telenti, A., Sudre, P., Cheseaux, J.-J., Halfon, P., Reymond, M. J., Marcovina, S. M., Glauser, M. P., Nicod, P., Darioli, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.7.700 · Cited by 605
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D., Hoh, R., Neese, R., Macallan, D., et al. (1999) · Nature Medicine · doi:10.1038/4772 · Cited by 593
Self-citationZhou, X., Nicoletti, A., Elhage, R., & Hansson, G. K. (2000) · Circulation · doi:10.1161/01.cir.102.24.2919 · Cited by 554
Walli, R., Herfort, O., Michl, G. M., Demant, T., Jäger, H., Dieterle, C., Bogner, J. R., Landgraf, R., & Goebel, F. D. (1998) · AIDS · doi:10.1097/00002030-199815000-00001 · Cited by 519
Mulligan, K., Grunfeld, C., Tai, V. W., Algren, H., Pang, M., Chernoff, D. N., Lo, J. C., & Schambelan, M. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200001010-00005 · Cited by 518
Self-citationSevere premature coronary artery disease with protease inhibitors
Henry, K., Melroe, H., Huebsch, J., Hermundson, J., Levine, C., Swensen, L., & Daley, J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79053-x · Cited by 513
Protease inhibitors and cardiovascular outcomes in patients with HIV-1
Holmberg, S. D., Moorman, A. C., Williamson, J. M., Tong, T. C., Ward, D. J., Wood, K. C., Greenberg, A. E., & Janssen, R. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11672-2 · Cited by 488
Stein, J. H., Klein, M. A., Bellehumeur, J. L., McBride, P. E., Wiebe, D. A., Otvos, J. D., & Sosman, J. M. (2001) · Circulation · doi:10.1161/01.cir.104.3.257 · Cited by 479
Hazenberg, M. D., Stuart, J. W. T. C., Otto, S. A., Borleffs, J. C. C., Boucher, C. A. B., de Boer, R. J., Miedema, F., & Hamann, D. (2000) · Blood · doi:10.1182/blood.v95.1.249 · Cited by 450
Salomon, R., Hughes, C. C. W., Schöen, F. J., Payne, D. D., Pober, J. S., & Libby, P. (1991) · PubMed · Cited by 372
Chambless, L. E. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.1.38 · Cited by 321
Premature atherosclerosis in HIV-infected individuals – focus on protease inhibitor therapy
Depairon, M., Chessex, S., Sudre, P., Rodondi, N., Doser, N., Chave, J.-P., Riesen, W., Nicod, P., Darioli, R., Telenti, A., et al. (2001) · AIDS · doi:10.1097/00002030-200102160-00005 · Cited by 273
Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors
Maggi, P., Serio, G., Epifani, G., Fiorentino, G., Saracino, A., Fico, C., Perilli, F., Lillo, A., Ferraro, S., Gargiulo, M., et al. (2000) · AIDS · doi:10.1097/00002030-200011100-00001 · Cited by 240
Liu, Z., Cumberland, W. G., Hultin, L. E., Kaplan, A. H., Detels, R., & Giorgi, J. V. (1998) · Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology · doi:10.1097/00042560-199808010-00004 · Cited by 237
Valdez, H., Connick, E., Smith, K. Y., Lederman, M. M., Bosch, R. J., Kim, R. S., St. Clair, M., Kuritzkes, D. R., Kessler, H., Fox, L., et al. (2002) · AIDS · doi:10.1097/00002030-200209270-00002 · Cited by 211
Notermans, D. W., Jurriaans, S., de Wolf, F., Foudraine, N. A., de Jong, J. J., Cavert, W., Schuwirth, C. M., Kauffmann, R. H., Meenhorst, P. L., McDade, H., et al. (1998) · AIDS · doi:10.1097/00002030-199802000-00006 · Cited by 185
Carotid intima-media thickness measurements: what defines an abnormality? A systematic review.
Aminbakhsh, A., & Mancini, G. B. J. (1999) · PubMed · Cited by 170
Whisnant, J. P., Homer, D., Ingall, T. J., Baker, H. L., O'Fallon, W. M., & Wievers, D. O. (1990) · Stroke · doi:10.1161/01.str.21.5.707 · Cited by 159
Mercié, P., Thiébaut, R., Aurillac-Lavignolle, V., Pellegrin, J., Yvorra-Vives, M. C., Morlat, P., Ragnaud, J., Dupon, M., Malvy, D. J.-M., Bellet, H., et al. (2002) · Annals of Medicine · doi:10.1080/078538902317338652 · Cited by 140
Reliability of Longitudinal Ultrasonographic Measurements of Carotid Intimal-Medial Thicknesses
Espeland, M. A., Craven, T. E., Riley, W. A., Corson, J. D., Romont, A., & Furberg, C. D. (1996) · Stroke · doi:10.1161/01.str.27.3.480 · Cited by 134
Freeman, D. J., Griffin, B. A., Murray, E. F., Lindsay, G. M., Gaffney, D., Packard, C. J., & SHEPHERD, J. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00724.x · Cited by 133
Seminari, E. M., Pan, A., Voltini, G., Carnevale, G., Maserati, R., Minoli, L., Meneghetti, G., Tinelli, C., & Testa, S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00736-5 · Cited by 127
Zangerle, R., Sarcletti, M., Gallati, H., Reibnegger, G. J., WACHTER, H., & Fuchs, D. (1994) · PubMed · Cited by 97
Meng, Q., Lima, J. A. C., Lai, H. C., Vlahov, D., Celentano, D. D., Strathdee, S. A., Nelson, K. E., Wu, K. C., Chen, S., Tong, W., et al. (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)00135-7 · Cited by 90
Lederman, M. M., Kalish, L. A., Asmuth, D. M., Fiebig, E. W., Mileno, M. D., & Busch, M. P. (2000) · AIDS · doi:10.1097/00002030-200005260-00006 · Cited by 74
Wu, K. K., Folsom, A. R., HEISS, G. M., DAVIS, C. E., Conlan, M. G., & Barnes, R. W. (1992) · Annals of Epidemiology · doi:10.1016/1047-2797(92)90097-a · Cited by 69
Hyperlipidemia under treatment with proteinase inhibitors
Segerer, S., Bogner, J. R., Walli, R., Loch, O., & Goebel, F. D. (1999) · Infection · doi:10.1007/bf02560501 · Cited by 69
Carotid Intima-Media Thickness in Heavily Pretreated HIV-Infected Patients
Chironi, G. N., Escaut, L., Gariépy, J., Cogny, A., Monsuez, J.-J., Levenson, J. A., Simon, A. C., & Vittecoq, D. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200304150-00004 · Cited by 67
Cited by
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
Grinspoon, S., & Carr, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041811 · Cited by 1,070
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Immune activation and inflammation in HIV‐1 infection: causes and consequences
Appay, V, & Sauce, D. (2008) · The Journal of Pathology · doi:10.1002/path.2276 · Cited by 743
Lorenz, M. W., Polak, J. F., Kavousi, M., Mathiesen, E. B., Völzke, H., Tuomainen, T.-P., Sander, D., Plichart, M., Catapano, A. L., Robertson, C. M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60441-3 · Cited by 598
Metadata
- Authors
- Hsue, P. Y., Lo, J. C., Franklin, A., Bolger, A. F., Martin, J. N., Deeks, S. G., & Waters, D. D.
- Venue
- Circulation
- Published
- 2004-04-06
- Volume
- 109
- Issue
- 13
- Pages
- 1603-1608
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2063170999
- Cited by
- 588
- References
- 44
- FWCI
- 41.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.